Sensors, machine learning used in movement disorder diagnosis
Integrating movement sensors and machine learning approaches may aid a correct diagnosis of movement disorders, including essential tremor and myoclonus,…
Articles by Andrea Lobo
Parkinson’s Foundation names new accredited exercise providers
The Parkinson’s Foundation now recognizes Dance for PD and Parkinson’s Pointe as accredited exercise education providers, a…
Gene therapy AAV-GAD wins RMAT designation for Parkinson’s
The U.S. Food and Drug Administrated (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) status to AAV-GAD, MeiraGTx’s gene…
Students aim to boost diversity in Parkinson’s exercise providers
Two University of Michigan-Flint doctorate students received a $50,000 grant to support diversity among exercise providers offering care to people…
AI tools may help detect, diagnose Parkinson’s at early stages: Study
Using advanced diagnostic tools — such as different types of brain scans and methods that employ artificial intelligence (AI) —…
MJFF expands training program for movement disorder specialists
The Michael J. Fox Foundation (MJFF) is expanding the size and reach of its global Edmond J. Safra Fellowship…
RNA-editing enzyme may be novel treatment target in Parkinson’s
The dysregulation of RNA editing within astrocytes (neuron-supporting cells) seems to induce chronic inflammation and ultimately contributes to the loss…
Exercise, fall risk, caregiver burden focus of UAMS Parkinson’s meeting
Physical exercise, avoiding falls, and the importance of providing support to caregivers were the focus of the 10th UAMS…
Psilocybin eases depression, anxiety in Parkinson’s: Pilot trial
Low-dose psilocybin, a naturally occurring psychedelic compound, may be a promising therapy for mood issues including depression and anxiety in…
IC 100 reduces inflammasome activation, alpha-synuclein clumps
Blocking the inflammatory protein ASC with IC 100, ZyVersa Therapeutics’ experimental therapy to reduce inflammation, prevented the activation of…